BioArtemis GmbH

BioArtemis combines deep medical expertise with strategic business insight to accelerate life sciences innovations from early drug development to successful market launch, and investment. Founded by Siham Ceballos PhD MBA, a biotech executive with over 15 years of experience leading drug program manag, medical affairs, and venture strategy, BioArtemis supports clients in navigating complex challenges and unlocking growth. Services for Biotech Companies • Drug Development & Program Management: Guidance across preclinical and clinical stages, including trial design, regulatory strategy, and portfolio optimization to efficiently advance innovative therapies. • Medical Affairs: Building, scaling, and leading international medical affairs organizations. Expertise in pre-launch, launch, and post-launch activities. • Fundraising Support: Targeted investor selection and introductions, plus pitch deck optimization to clearly communicate value propositions and maximize fundraising success. Services for Investors and Family Offices • Strategic Opportunity Sourcing: Identifying and evaluating high-potential biotech ventures aligned with your investment strategy, leveraging an extensive network and scientific insight. • Comprehensive Due Diligence: Conducting thorough scientific, clinical, and commercial assessments to provide actionable insights and mitigate investment risks. • Portfolio Management: Supporting investment strategy optimization, monitoring progress, and driving venture growth. Why Partner with BioArtemis? • Proven success with Rejuveron Life Sciences, Alnylam, Biogen, Celgene, and Pfizer. • Unique blend of scientific rigor and business acumen bridging innovation and capital. • Global perspective with strong ties in Europe and the US, experienced in remote collaboration and cross-border operations. • Passionate about helping companies achieve strategic milestones and deliver transformative therapies to patients worldwide. e-mail: siham.ceballos@bioartemis.com